C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2004
11/25/2004	WO2004101738A2 Domain-exchanged binding molecules, methods of use and methods of production
11/25/2004	WO2004101736A1 Apparatus for culturing organism and culture method
11/25/2004	WO2004101733A1 A pcr amplification device used for multi-steps reaction and a wash-free pcr amplification tube used for direct gene detection
11/25/2004	WO2004101730A1 Microparticle based biochip systems and uses thereof
11/25/2004	WO2004101536A1 Novel phenoxazinone derivatives as enzyme substrates and use thereof as indictor in the detection of microorganisms with peptidase activity
11/25/2004	WO2004101369A2 Selectively deformable container end closure
11/25/2004	WO2004100986A2 Pharmaceutical use of an adam 10 inhibitory substance
11/25/2004	WO2004100974A1 USE OF Hab 18G/CD 147 MOLECULE AS TARGET OF ANTIVIRAL ANTAGONIST AND THUS OBTAINED ANTIVIRAL ANTAGONIST
11/25/2004	WO2004100636A2 Method for modifying transcription and/or translation in an organism
11/25/2004	WO2004095221A3 Apparatus and methods for analyzing and characterizing nucleic acid sequences
11/25/2004	WO2004093662A3 Method for detecting prognosis of cancer
11/25/2004	WO2004091511A3 Compositions and methods to diagnose and treat lung cancer
11/25/2004	WO2004087965A3 Statistical analysis of regulatory factor binding sites of differentially expressed genes
11/25/2004	WO2004087950A3 Improved system for multi color real time pcr
11/25/2004	WO2004085468A3 Human p53 splice variant displaying differential transcriptional activity
11/25/2004	WO2004081225A3 Amplification and analysis of whole genome and whole transcriptome libraries generated by a dna polymerization process
11/25/2004	WO2004078123A3 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use
11/25/2004	WO2004075831A3 Pharmacodynamic assay for inhibitors of 11-beta-hydroxysteroid dehydrogenase activity in animal tissues
11/25/2004	WO2004074428A3 Treatment of metabolic disorders
11/25/2004	WO2004072247A3 Polymerase-based protocols for generating chimeric and combinatorial chimeric oligonucleotides
11/25/2004	WO2004070057A3 Use of a novel polymorphism in the hsgk1 gene in the diagnosis of hypertonia and use of the sgk gene family in the diagnosis and therapy of the long qt syndrome
11/25/2004	WO2004068112A3 Hairpin primer amplification
11/25/2004	WO2004067032A3 Identification of gene sequences and proteins involved in vaccinia virus dominant t cell epitopes
11/25/2004	WO2004053454A8 Methods for detecting invasion of a cell
11/25/2004	WO2004053063A3 Molecular determinants of myeloma bone disease and uses thereof
11/25/2004	WO2004051774A3 Enzyme immobilization for use in biofuel cells and sensors
11/25/2004	WO2004045364A3 Methods of detecting ovarian neoplasia
11/25/2004	WO2004038036A3 Methods of assaying for modulators of the inflammatory process using components of the ubiquitin ligation cascade
11/25/2004	WO2004033712A3 Assays for c-mannosyltransferase
11/25/2004	WO2004033711A3 Screening assay for identifying agents that modulate pak kinase or cd45 tyrosine phosphatase activity
11/25/2004	WO2004029084A3 Lipase inhibitors and uses thereof
11/25/2004	WO2004027378A3 Luminescence-based methods and probes for measuring cytochrome p450 activity
11/25/2004	WO2004008938A3 A novel method to identify targets for antibiotic development
11/25/2004	WO2003102142A3 Arrays identifying genomic and proteomic biomarkers for cystic fibrosis
11/25/2004	WO2003094847A3 Compositions and methods for identifying antiviral agents
11/25/2004	WO2003086280A3 Immunostimulatory g,u-containing oligoribonucleotides
11/25/2004	WO2003081509A3 DATA MINING OF SNP DATABASES FOR THE SELECTION OF INTRAGENIC SNPs
11/25/2004	WO2003080871A8 Method for detection and differentiation of mycobacterium tuberculosis complex
11/25/2004	WO2003074662A3 SCDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
11/25/2004	WO2003072805A3 Recombinase polymerase amplification
11/25/2004	WO2003021229A3 Diagnostic and prognostic tests
11/25/2004	WO2002086097A8 Methods for identifying the target of a compound which inhibits cellular proliferation
11/25/2004	WO2002020556A3 Haplotypes of the gpr68 gene
11/25/2004	WO2002019602A3 Statistical modeling to analyze large data arrays
11/25/2004	WO2002014538A3 Rational panel design method for microbiological investigations
11/25/2004	US20040237141 Plant gene regeneration; hybrids; reducing glucosinolates
11/25/2004	US20040237139 Production of hydroxylated fatty acids in genetically modified plants
11/25/2004	US20040237134 Wheat plants having increased resistance to imidazoline herbicides
11/25/2004	US20040237127 Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
11/25/2004	US20040236518 Method and apparatus for comining gene predictions using bayesian networks
11/25/2004	US20040236517 Selection of target sites for antisense attack of rna
11/25/2004	US20040236516 Bioinformatics based system for assessing a condition of a performance animal by analysing nucleic acid expression
11/25/2004	US20040236094 Using triplex complexes to generate preferential nucleotide sequences; in vitro DNA synthesis
11/25/2004	US20040236093 Using chimeric dendritic cells comprising viral epitopes to generate vaccines to prevent and treat viral diseases
11/25/2004	US20040236081 Immunoglobulin which binds interleukkin-1bconverting enzyme for use in diagnosis, treatment and prevention of autoimmune, neurodegenerative and cell proliferative disorders
11/25/2004	US20040236072 Immunogenic polynucleotides, polypeptides, and antibodies used for detecting, immunizing against, and reducing beta-hemolytic streptococcal infection
11/25/2004	US20040235776 Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer
11/25/2004	US20040235766 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication
11/25/2004	US20040235764 Methods of inhibiting expression of a target gene in mammalian cells
11/25/2004	US20040235740 Administered as antitumor, antimetastasis, anticarcinogenic and/or wound healing agent; tissue regeneration
11/25/2004	US20040235723 Introducing ABC protein gene into yeast cell having high drug sensitivity to prepare transformed cell where protein is expressed in cell membrane, incubating cell in presence of test substance and substance which is subjected to active transfer outside cell by ABC protein in cell membrane, comparing
11/25/2004	US20040235722 Assay that makes use of the interaction of early pregnancy factor (EPF) or an EPF-related peptide with a human dorsal root receptor (hDRR) or hDRR related receptor; also useful to determine whether the test compound is an agonist or antagonist of hDRRs
11/25/2004	US20040235199 Method for fabricating a nanoarray using the self-assembly of supramolecules and staining of metals
11/25/2004	US20040235185 Amine oxide of diaminophenyl oxadiazole derivatives as detection agent for detecting glucose, lactate, alcohol, galactose, cholesterol, fructose, glycerol, pyruvate, creatinine, alanine, phenylalanine, leucine, triglycerides or HDL cholesterol analytes
11/25/2004	US20040235156 Therapeutic mixture comprising interferons and chimeric immunoglobulins for use in activation of immune response and treatment, diagnosis and prevention of cancer; immunotherapy; tissue targeted therapy
11/25/2004	US20040235148 Reaction vessel and reaction vessel holding mechanism
11/25/2004	US20040235138 Compositions, methods and kits for determining the presence of Trichomonas vaginalis in a test sample
11/25/2004	US20040235134 Newcastle disease virus infectious clones, vaccines and new diagnostic assays
11/25/2004	US20040235129 KDEL receptor inhibitors
11/25/2004	US20040235116 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
11/25/2004	US20040235113 18 human secreted proteins
11/25/2004	US20040235106 18891, a novel human lipase
11/25/2004	US20040235103 In vitro transfromation; polypeptides; genetic engineering
11/25/2004	US20040235102 Comprises adenosine triphosphate binding cassette membrane protein for use in identifying modulator which prevent transport of neurotoxic molecules; treating nervous system disorders
11/25/2004	US20040235098 Sulfotransferase sequence variants
11/25/2004	US20040235097 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
11/25/2004	US20040235092 Comprises expression vectors coding heterologous protein for use as tools in diagnosis and treatment of cell proliferative, nervous system, inflammatory and autoimmune diseases
11/25/2004	US20040235091 Preparing protease resistant, bioactive amino acid sequences for use as therapeutic peptides; biodrugs; mimetics
11/25/2004	US20040235087 Test media and quantitative or qualitative method for identification and differentiation of biological materials in a test sample
11/25/2004	US20040235086 Detection of cellular contaminants in samples of non-living material
11/25/2004	US20040235085 Use of ylqF, yqeG, yybQ, and ysxC, essential bacterial genes and polypeptides
11/25/2004	US20040235084 biomimic cofactor; 3-substituted pyridium compounds; nicotinamides N-substituted with benzyl or polyoxyethylene glycol derivatives; bipyridyl rhodium hydride complex catalyst for reduction of the cofactor; polymer matrix; economical in large scale; biosensor or a chemical membrane bioreactor
11/25/2004	US20040235083 Screening method
11/25/2004	US20040235082 Fat regulation
11/25/2004	US20040235081 enzyme substrate is a flavonoid-substituted catechol chromogen attached to a cleavable sugar via an ester or ether group; colorimetric analysis with the nondiffusable colored catechol residue chelate compound; visible detection of anaerobic bacteria on a solid medium
11/25/2004	US20040235080 Mixture comprising recombinantly produced horseshoe crab Factor C protein and a surfactant for detection of gram negative bacterial endotoxin; monitoring purity of food and water and drugs
11/25/2004	US20040235079 Identifying modulators associated with heme independent inhibition of soluble guanylyl cyclase for use in treatment of infection, hypertension and cardiovascular disorders
11/25/2004	US20040235078 Kits for screening for blood coagulation disorders
11/25/2004	US20040235077 Luciferase and methods for measuring intracellular ATP using the same
11/25/2004	US20040235075 Rapid immunoassay of anthrax protective antigen in vaccine cultures and bodily fluids by fluorescence polarization
11/25/2004	US20040235073 Using nuclear and lower cytosolic localization of kruppel-like transcription factors to diagnose and prognose viability of individuals with cell proliferative disorders
11/25/2004	US20040235072 Compositions and methods for the therapy and diagnosis of lung cancer
11/25/2004	US20040235067 Stain-directed molecular analysis for cancer prognosis and diagnosis
11/25/2004	US20040235066 Using immunoglobulin specific to cancer testis-antigens for use in diagnosis and treatment of cell proliferative diseaes; immunotherapy
11/25/2004	US20040235063 Exposing mammalian cells to plant extract, lyse tested mammalian cells and compare pattern of phosphorylated proteins to pattern of phosphorylated proteins in control cells, evaluate for bioactivity; identifying medicinal plant components
11/25/2004	US20040235060 Biosensor for defecting chemical agents
11/25/2004	US20040235058 ULBP antibodies
11/25/2004	US20040235054 Novel encoding method for "one-bead one-compound" combinatorial libraries
11/25/2004	US20040235053 Preparation and application of encoded bead aggregates in combinatorial chemistry
11/25/2004	US20040235045 Method for disease prognosis based on Fc receptor genotyping

1 ... 1828 1829 1830 1831 1832 1833 1834 1835 1836 1837 1838 1839 1840 1841 1842 1843 1844 1845 1846 1847 1848 ... 3003